Reactive Arthritis: Treatment Challenges and Future Perspectives
- 26 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Current Rheumatology Reports
- Vol. 22 (7), 1-7
- https://doi.org/10.1007/s11926-020-00904-9
Abstract
Purpose of the Review Reactive arthritis is synovitis related to an infection away from the joint. The evolution is variable, frequently self-limited, but with the possible evolution to a prolonged form, generating functional incapacity and sequelae. Recent Findings New microbiological families have been incriminated and pathophysiological links have been clarified, highlighting the role of the mucous membranes (gut in particular), specific cell populations, and the production of pro-inflammatory cytokines. First-line pharmacological treatment is based on NSAIDs. In case of failure, synthetic and more recently biological DMARDs are indicated. Only open data are available for biological DMARDs but suggest good efficacy and safety. Summary Reactive arthritis has not disappeared. The diagnosis must be mentioned by the clinic and history to allow the rapid introduction of an appropriate treatment.Keywords
This publication has 44 references indexed in Scilit:
- Antibiotics for Treatment of Reactive Arthritis: A Systematic Review and MetaanalysisThe Journal of Rheumatology, 2013
- Safety and efficacy of anti–tumor necrosis factor α therapy in ten patients with recent‐onset refractory reactive arthritisArthritis & Rheumatism, 2011
- Combination antibiotics as a treatment for chronic Chlamydia‐induced reactive arthritis: A double‐blind, placebo‐controlled, prospective trialArthritis & Rheumatism, 2010
- Prolonged Remission of Chronic Reactive Arthritis Treated With Three Infusions of InfliximabJCR: Journal of Clinical Rheumatology, 2010
- Successful treatment of reactive arthritis with a humanized anti–interleukin‐6 receptor antibody, tocilizumabArthritis Care & Research, 2009
- Successful use of infliximab in the treatment of Reiter’s syndrome: a case report and discussionClinical Rheumatology, 2007
- Use of Adalimumab in Poststreptococcal Reactive ArthritisJCR: Journal of Clinical Rheumatology, 2007
- Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: An open-label trialArthritis & Rheumatism, 2005
- Treatment of reactive arthritis with infliximabScandinavian Journal of Rheumatology, 2003
- Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathyRheumatology, 1996